The selling is routine portfolio diversification following option exercises, not a bearish signal. Monitor for any 8-K filings or clinical trial updates that could explain the timing, but the dollar amount is too small to warrant action.
How the stock moved after the report
⚠ Clustered NEUTRAL VIEWSTOCK BELOW ENTRY AT T+60- T+0 · Aug 12 $112.41entry
- T+1 · 3mo ago −2.50%α −3.20% · $109.60
- T+5 · 3mo ago +1.15%α +1.59% · $113.70
- T+20 · 2mo ago −8.12%α −6.22% · $103.28
- T+60 · 12d ago −26.15%α −21.04% · $83.01
Price Chart
REPLAYWatch the reaction play outHow similar events traded
Executive Summary
A cluster of insider selling at Dianthus Therapeutics (DNTH) totaling $2.99M over a 7-day window, led by the CEO ($1.12M) and General Counsel ($1.78M). The selling is concentrated at prices near $107-$111, representing ~0.05% of the $6.1B market cap, which is below the 0.1% materiality threshold. While C-suite participation adds weight, the absolute dollar amount is trivial relative to market cap, and the selling is likely liquidity-driven following option exercises rather than a bearish signal.
Key Financial Metrics
Key Facts
- Total insider selling of $2.99M over 7 days, representing ~0.05% of $6.1B market cap
- CEO Marino Garcia sold $1.12M (10.4K shares at $107.49) on 2026-08-07
- General Counsel Adam Veness sold $1.78M (16.2K shares at $110.38) on 2026-08-10
- All sales are open-market; several insiders also exercised options at low strike prices ($0-$19.36) on same day
- No insider buying in the cluster; net direction is entirely selling
Financial Impact
$2.99M in open-market sales, ~0.05% of market cap, immaterial
Risk Factors
- CEO selling $1.12M could be misinterpreted as a negative signal by the market
- Cluster selling may accelerate if stock continues to rise, creating overhead supply
- No insider buying to offset the selling pattern
Market Snapshot
Investment Themes
Documents Analyzed
This report is based on 1 SEC document filed with EDGAR.
| Document | Accession Number |
|---|---|
| CLUSTER Data (Synthetic) | cluster-DNTH-1786526069166 |
Track record
23 reports on DNTH
7 of 8 bullish or bearish reports moved the stock their way by T+1. Best: +41.40% at T+60 after the Jun 11, 2026 report. 8 of 8 went positive at some point.
Filters
- Nov 16, 2026today SC 13G/A Neutral 3/10 Entry $89.76 Now $89.55 −0.23% settles Nov 17
- Nov 9, 20267d ago 144 Neutral 3/10 Entry $88.81 to $89.30 Now $89.55 +0.83% ▲ +0.55% −0.77% vs SPY
- Nov 4, 202612d ago 8-K Neutral 4/10 No price data
- Nov 4, 202612d ago Press Release Neutral 4/10 Entry $83.01 to $86.03 Now $89.55 +7.88% ▲ +3.64% +3.33% vs SPY
- Oct 30, 202617d ago Institutional Cluster Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
- Oct 30, 202617d ago SC 13G Neutral 3/10 Entry $82.38 to $82.25 Now $89.55 +8.70% ▼ −0.16% +0.32% vs SPY
- Oct 12, 20265w ago Institutional Cluster Mixed 3/10 Entry $81.57 to $77.58 Now $89.55 +9.78% ▼ −4.89% −4.88% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 4/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 3/10 Viewing Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
- Aug 11, 202613w ago Insider Cluster Neutral 3/10 Entry $112.41 to $109.60 Now $89.55 −20.34% ▼ −2.50% −3.20% vs SPY
US Market Status
Subscribe to SecBot
Get Real-Time SEC Filing Intelligence
Comprehensive SEC filing analysis delivered the moment filings hit EDGAR. Sentiment scoring, impact analysis, and actionable insights for every material event.
Create a free account Live analysis, Telegram alerts, watchlists and the MCP server for subscribers